Literature DB >> 16724568

Time of vaccination influences development of adhesions, growth and spinal deformities in Atlantic salmon Salmo salar.

Arne Berg1, Odd Magne Rødseth, Arild Tangerås, Tom Hansen.   

Abstract

In August 1998, 3000 Atlantic salmon Salmo salar L. parr were divided into 7 groups with 2 replicates. Every 6 wk until March of the following year 1 group was vaccinated. One group was held as an unvaccinated control. The fish were transferred to seawater in May 1999, and slaughtered in February 2000. Temperature, fish size and photoperiod at vaccination, and the time between vaccination and sea transfer thus varied among the groups. In all vaccinated groups, growth was reduced for 1 to 2 mo following vaccination. Intra-abdominal lesions developed faster, and stabilised at a higher level in the groups vaccinated early at the highest temperature and the smallest fish size. Growth in seawater was influenced by the time of vaccination. At the end of the experiment, the group vaccinated last (MAR) was the heaviest of the vaccinated groups (4.0 kg), and the group vaccinated first, i.e. in August (AUG) was smallest (3.2 kg). Growth rate in seawater differed only in the summer when specific growth rate was above 1.45 in all groups. There was a correlation between adhesion, condition factor and number of weeks from vaccination to sea transfer. The AUG group had the highest condition factor, with a top level of 1.64 in autumn, and this group also displayed the highest incidence of deformed vertebra. The experiment shows that side effects of vaccination can be significantly reduced when planning the vaccination strategy, by taking environmental factors and fish biology into consideration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16724568     DOI: 10.3354/dao069239

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  9 in total

1.  The effects of increasing dietary levels of amino acid-supplemented soy protein concentrate and constant dietary supplementation of phosphorus on growth, composition and immune responses of juvenile Atlantic salmon (Salmo salar L.).

Authors:  C Metochis; V O Crampton; K Ruohonen; J G Bell; A Adams; K D Thompson
Journal:  Fish Physiol Biochem       Date:  2016-01-18       Impact factor: 2.794

2.  Digestive efficiency, free amino acid pools and quality of growth performance in Atlantic salmon (Salmo salar L.) affected by light regimes and vaccine types.

Authors:  Krisna Rungruangsak-Torrissen; Jan Sunde; Arne Erik Berg; Ulla Nordgarden; Per Gunnar Fjelldal; Frode Oppedal
Journal:  Fish Physiol Biochem       Date:  2008-03-11       Impact factor: 2.794

3.  Aeromonas salmonicida binds differentially to mucins isolated from skin and intestinal regions of Atlantic salmon in an N-acetylneuraminic acid-dependent manner.

Authors:  János T Padra; Henrik Sundh; Chunsheng Jin; Niclas G Karlsson; Kristina Sundell; Sara K Lindén
Journal:  Infect Immun       Date:  2014-10-06       Impact factor: 3.441

4.  Successive Oral Immunizations Against Piscirickettsia Salmonis and Infectious Salmon Anemia Virus are Required to Maintain a Long-Term Protection in Farmed Salmonids.

Authors:  Iván Tobar; Sergio Arancibia; Constanza Torres; Verónica Vera; Paola Soto; Claudia Carrasco; Marcelo Alvarado; Eduardo Neira; Sandra Arcos; Jaime A Tobar
Journal:  Front Immunol       Date:  2015-05-27       Impact factor: 7.561

5.  Coinfection takes its toll: Sea lice override the protective effects of vaccination against a bacterial pathogen in Atlantic salmon.

Authors:  Carolina Figueroa; Paulina Bustos; Débora Torrealba; Brian Dixon; Carlos Soto; Pablo Conejeros; José A Gallardo
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

6.  Response of triploid Atlantic salmon (Salmo salar) to commercial vaccines.

Authors:  Lynn Chalmers; Herve Migaud; Alexandra Adams; Luisa M Vera; Elsbeth McStay; Ben North; Chris Mitchell; John F Taylor
Journal:  Fish Shellfish Immunol       Date:  2019-12-23       Impact factor: 4.581

7.  A comparison of the response of diploid and triploid Atlantic salmon (Salmo salar) siblings to a commercial furunculosis vaccine and subsequent experimental infection with Aeromonas salmonicida.

Authors:  Lynn Chalmers; Kim D Thompson; John F Taylor; Sean Black; Herve Migaud; Ben North; Alexandra Adams
Journal:  Fish Shellfish Immunol       Date:  2016-08-25       Impact factor: 4.581

Review 8.  Nanodelivery Systems as New Tools for Immunostimulant or Vaccine Administration: Targeting the Fish Immune System.

Authors:  Jie Ji; Debora Torrealba; Àngels Ruyra; Nerea Roher
Journal:  Biology (Basel)       Date:  2015-10-19

9.  Alternatives to mineral oil adjuvants in vaccines against Aeromonas salmonicida subsp. salmonicida in rainbow trout offer reductions in adverse effects.

Authors:  Kasper Rømer Villumsen; Erling Olaf Koppang; Dennis Christensen; Anders Miki Bojesen
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.